You are here: Industry Insights > NIH

News List

Trump administration block NIH researchers from using foetal tissue, disrupting research to cure HIV pharmafile
December 11, 2018
The Trump Administration has halted the acquisition of new human foetal tissue for use in experiments conducted by NIH researchers, thus disrupting research into a cure for HIV.
Gene Therapy for Sickle Cell Takes Another Step Forward drugs
December 05, 2018
A new gene therapy shows early promise against sickle cell anemia, researchers say.The therapy targets the genetic flaw that causes sickle cell.......
Integral Molecular Awarded $1.4 Million by NIH americanpharmaceuticalreview
December 05, 2018
Integral Molecular was awarded $1.4M by the NIH to develop its lead antibodies against cannabinoid receptor 1 (CB1) for treating the liver disease nonalcoholic.....
NIH grants IDT 10-year vaccine manufacturing contract fiercepharma
December 04, 2018
IDT Biologika has won a 10-year contract worth up to $80 million from the NIH’s National Institute of Allergy and Infectious Diseases to make vaccines and biologics for infectious diseases.
NIH to evaluate effectiveness of male contraceptive skin gel cphi-online
December 03, 2018
The gel formulation includes the progestin compound segesterone acetate, in combination with testosterone, and is applied to the back and shoulders and absorbed through the skin.
NIH Awards Grant for Research on Apexian's APX3330 as Treatment for Cancer Cachexia americanpharmaceuticalreview
October 30, 2018
NIH Awards Grant for Research on Apexian's APX3330 as Treatment for Cancer Cachexia
IDT Biologika Awarded 10-Year NIH Contract contractpharma
October 19, 2018
Will manufacture vaccines and biologics for infectious diseases
AgeneBio Announces Two NIH Grant Awards americanpharmaceuticalreview
October 12, 2018
AgeneBio announced two grant awards to advance their approaches to slowing progression of mild cognitive impairment (MCI) due to Alzheimer's Disease (AD).
SiteOne Therapeutics Receives NIH Grant americanpharmaceuticalreview
September 27, 2018
SiteOne Therapeutics announced the company has been awarded a $1.4 million, two-year, Phase 2 SBIR grant from the National Eye Institute (NEI), a member of the US National Institutes of Health (NIH).
NIH to accelerate genetic therapies for sickle cell disease biospectrumasia
September 18, 2018
The initiative and its research partners will establish a national data warehouse of genetic therapies for sickle cell disease.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page